BSE filing, NSE: ALCHCORP. Summary written from the filing by ALFA Finder's alert engine.
Alchemist Corporation Ltd: key numbers
- Share price
- ₹36.97
- Market cap
- ₹18.17 Cr
- Revenue (annual)
- ₹5.17 Cr
- Net profit (annual)
- ₹-0.08 Cr
- P/E (TTM)
- -2064.2×Sector 36.4×
- Promoter holding
- 74.11%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alchemist Corporation Ltd
All →Alchmeist Corporation Board Meeting Date
Alchmeist Corporation schedules a board meeting on 29 October 2026 to approve unaudited half-year standalone and consolidated results. Trading window stays closed from 01 October to 31 October 2026.
Alchemist Corporation Other Announcement
Alchemist Corporation Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Alchemist Corporation Annual General Meeting
Alchemist Corporation Limited concluded its 33rd Annual General Meeting on September 29, 2026. The proceedings covered eight agenda items including financial statement adoption and related-party transaction approvals.
Alchemist Corporation Annual General Meeting
Alchemist Corporation Limited has issued a notice for its 33rd Annual General Meeting scheduled for September 29, 2026, to discuss various corporate and related-party matters.
Alchemist Corporation Annual Report
Alchemist Corporation filed its Annual Report for the financial year 2025-26, including the notice for the 33rd Annual General Meeting.
Alchemist Corporation Q1 FY27 Results: Net Profit ₹0 Cr
Alchemist Corporation Ltd reported revenue from operations of ₹4.2 Cr and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.